PRECISE-SG100K
PRECISE-SG100K is a comprehensive population study focusing on the health and well-being of around 100,000 Singaporean residents aged over 21 years, representing three major ethnic groups in Singapore, including Chinese, Malay and Indian ethnicities. The SG100K cohort was established in 2022 by drawing participants from four existing prospective cohorts (HELIOS, SPHS, SEED and SingHeart) and recruiting around 30,000 new participants. Participants completed comprehensive baseline assessments between 2022 and 2025, and their long-term health outcomes are being monitored through linkage with electronic medical records, disease registers and invitations for further follow-up.
Study design
Cohort, Cohort - research programme
Number of participants at first data collection
100,000 (participants)
Age at first data collection
21 - 84 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
The broader Singapore population.
Sample features
Country
Year of first data collection
2022
Primary Institutions
A*STAR Genome Institute of Singapore (A*STAR GIS)
Nanyang Technological University (NTU)
National University of Singapore (NUS)
Precision Health Research, Singapore (PRECISE)
Singapore Eye Research Institute (SERI)
Profile paper DOI
Funders
National Research Foundation (NRF)
Ongoing?
Yes
Data types collected
- Computer, paper or task testing (e.g. cognitive testing, theory of mind doll task, attention computer tasks)
- Interview – face-to-face
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Secondary data
- Self-report questionnaire – unspecified
- Wearable devices
- None
- None
- Existing research data
- Healthcare data
Engagement
Keywords
Consortia and dataset groups
